#64: Our Take, August 5, 2019
Episode description
In today’s Our Take read-in, we discuss several CMS initiatives announced last Monday. The email version of Our Take includes several important links to other final and proposed rules from CMS. To sign up for the weekly email brief, click here.
Other briefs include:
- Pfizer signed a definitive agreement to merge its Upjohn division with Mylan.
- HHS is working on a plan to allow the legal importation of prescription drugs.
- CMS denies Utah’s request for partial Medicaid expansion.
- Cigna and Memorial Sloan Kettering (MSK) sign a value-based agreement.
- Philadelphia’s Temple University will sell its Fox Chase Cancer Center to Thomas Jefferson University.
About Darwin Research Group
Darwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin’s client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.
CONNECT WITH US:
🌐 Follow Health Care Rounds on LinkedIn
🌐 Follow Darwin Research Group on LinkedIn
📺 Watch Health Care Rounds on YouTube
⚙️ Health Care Rounds is produced by Grippi Media